Lower-dosage pembrolizumab as subsequent treatment in pre-treated locally advanced nasopharyngeal carcinoma
Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus (EBV)-associated malignancy. Concurrent chemoradiation (CCRT) or systemic chemotherapy is the mainstay of first-line treatment of NPC. A recent study demonstrated a measurable response of metastatic NPC treated with pembrolizumab, an immune che...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2018-06-01
|
| Series: | Journal of Cancer Research and Practice |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S231130061730085X |